US07725L1026
US07725L1026
BeOne Medicines Ltd.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 5.343.033.000 | 3.810.241.000 | 40.2% |
| Cost of Revenue | 668.540.000 | 594.089.000 | 12.5% |
| Gross Profit | 4.674.493.000 | 3.216.152.000 | 45.3% |
| 4.227.357.000 | 3.784.351.000 | 11.7% | |
| Operating Income | 447.136.000 | -568.199.000 | 178.7% |
| Pretax Income | 416.854.000 | -533.001.000 | 178.2% |
| Net Income Common Stockholders | 286.933.000 | -644.786.000 | 144.5% |
| -- | -- | -- | |
| -- | -- | -- |